Acta Med. 2008, 51: 185-190
https://doi.org/10.14712/18059694.2017.22
Monitoring of Serum Levels of Angiogenin, ENA-78 and GRO Chemokines in Patients with Renal Cell Carcinoma (RCC) in the Course of the Treatment
References
1. S, Arik Z, Maly A, et al. Involvement of the CXC12/CXC4 pathway in the recovery of skin following burns. J Invest Dermatol 2006; 16:468–476.
<https://doi.org/10.1038/sj.jid.5700069>
2. C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: Friends or foes? Clin Exp Metastasis 2002; 19:247–258.
<https://doi.org/10.1023/A:1015587423262>
3. LM, Werb Z. Inflammation and Cancer. Nature 2002; 420:860–867.
<https://doi.org/10.1038/nature01322>
<PubMed>
4. JB, Strydom DJ, Lobb RR, et al. Isolation and characterisation of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985; 24:5480–5486.
<https://doi.org/10.1021/bi00341a030>
5. I, Kozin SV, Chernova O, et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428: 328–332.
<https://doi.org/10.1038/nature02329>
6. A, Kunz M, Kostlin S, et al. Hypoxya induced up-regulation of angiogenin in human malignant melanoma. Cancer Res 1999; 59:1578–1983.
7. RP, Huang R, Fan Y, Lin Y. Simultaneous detection of multiple cytokines from conditioned media and patient’s sera by an antibody-based protein array system. Anal Biochem 2001; 294:55–62.
<https://doi.org/10.1006/abio.2001.5156>
8. J, Shattuck-Brandt R, Haghnegahdar H, et al. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997; 62:588–97.
<https://doi.org/10.1002/jlb.62.5.588>
9. J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM. The role of CXC2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 2005; 175:5351–5357.
<https://doi.org/10.4049/jimmunol.175.8.5351>
10. W, Ouyang X, Agarwal A, et al. IL-10 Suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651–3660.
<https://doi.org/10.1681/ASN.2005030297>
11. C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000; 95:3032–3043.
12. J, Schoolmann S, Beyer A, Denzel C, Hohenberger W, Haupt W. Production of IL-6 and MCP-1 by the human peritoneum in vivo during major abdominal surgery. Shock 2000; 14(2):91–4.
<https://doi.org/10.1097/00024382-200014020-00002>
13. SF, Birner P, Stöckl J, et al. Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis. Am J Pathol 2002; 161:947–956.
<https://doi.org/10.1016/S0002-9440(10)64255-1>
<PubMed>
14. A, von der Ohe M, Kolling U, et al. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators. Immunol 2006; 119: 317–327.
<https://doi.org/10.1111/j.1365-2567.2006.02435.x>
<PubMed>
15. ML, Lutzky VP, Zittermann SI, et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunol 2005; 114:375–385.
<https://doi.org/10.1111/j.1365-2567.2005.02104.x>
<PubMed>
16. B, Teklote JR, Hartel M, Friess H, Buchler MW. Inflammatory response after abdominal surgery. Best Pract Res Clin Anaesthesiol 2004; 18:439–459.
<https://doi.org/10.1016/j.bpa.2003.12.006>
17. DF, Galkina E, Ley K, Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. AJP-Heart Circ Physiol 2005; 76:1976–1984.
<https://doi.org/10.1152/ajpheart.00153.2005>
18. DJ. The angiogenin. Cell Mol Life Sci 1998; 54:811–824.
<https://doi.org/10.1007/s000180050210>
<PubMed>
19. A, Patel JV, Lip GY. Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost 2006; 4:1864–1874.
<https://doi.org/10.1111/j.1538-7836.2006.01995.x>
20. K, Dolan JP, Tsung YL, Norton JA. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Cancer Res 2002; 62: 5069–75.
21. CC, Huang RP, Sommer M, et al. Array-based multiplexed screening and quantitation of human cytokines and chemokines. J Proteome Res 2002; 4: 337–43.
<https://doi.org/10.1021/pr0255203>
22. HW, Bichler KH, Feil G, Loeser W, Lahme S, Petri E. Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res 1999; 19:1537–1540.
23. Ch, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115:245–253.
<https://doi.org/10.1046/j.1523-1747.2000.00029.x>
24. FP, Sietses C, von Blomberg BM, Meijer S, Bonjer HJ, Cuesta MA. Systemic and peritoneal angiogenic response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum 2004; 47(10):1670–4.
<https://doi.org/10.1007/s10350-004-0660-6>
25. J, Tsuruta N, Ogata K, et al. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung. Cancer Lett 1997; 120:101–108.
<https://doi.org/10.1016/S0304-3835(97)00296-6>
26. A, Seandel M, Kupriyanova TA, et al. Proangiogenic role of neutrophillike inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood 2006; 107:317–327.
<https://doi.org/10.1182/blood-2005-04-1458>
<PubMed>


